New Haven Pharmaceuticals
New Haven Pharmaceuticals, Inc. Espero Pharmaceuticals Inc. has acquired worldwide rights to New Haven Pharmaceuticals Inc.’s FDA-approved Durlaza (aspirin) extended-release capsules. February 2017.
See: Espero Biopharma
New Haven Pharmaceuticals, Inc. Espero Pharmaceuticals Inc. has acquired worldwide rights to New Haven Pharmaceuticals Inc.’s FDA-approved Durlaza (aspirin) extended-release capsules. February 2017.
See: Espero Biopharma
